SCHEMBL932848

SCHEMBL932848

O=C(O)c1ccccc1-c1cccs1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.53
LMNA P02545 1/20 0.53
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.48
GPR35 Q9HC97 2/20 0.48
FTO Q9C0B1 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
PTPN1 P18031 1/20 0.46
MYC P01106 1/20 0.46
DAO P14920 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX12 P18054 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11801296 0.84 KDM4E (0.44) ALOX15LMNAKDM4EGPR35FTO
SCHEMBL6732189 0.84 HPGDS (0.53) ALOX15LMNAKDM4EALDH1A1MEN1
SCHEMBL1023432 0.83 ALDH1A1 (0.42) ALOX15LMNAKDM4EALDH1A1FTO
SCHEMBL3559657 0.83 ALDH1A1 (0.54) KDM4EALDH1A1MEN1KMT2ANPC1
SCHEMBL11678330 0.83 HCRTR1 (0.44) LMNAKDM4EALDH1A1L3MBTL1MAPT
SCHEMBL27204316 0.83 BAZ2B (0.53) LMNAKDM4EALDH1A1L3MBTL1MAPT
SCHEMBL1823757 0.82 GPR35 (0.52) ALOX15LMNAKDM4EALDH1A1GPR35
SCHEMBL7159232 0.82 G6PD (0.49) ALOX15LMNAKDM4EALDH1A1GPR35
SCHEMBL4596567 0.82 KDM4E (0.51) ALOX15LMNAKDM4EALDH1A1GPR35
SCHEMBL7125127 0.82 DHODH (0.49) ALOX15LMNAKDM4EALDH1A1GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105669506-B A kind of synthetic method of 2 thiophenyl benzoic acid 温州大学 2018-02-06 CN claimed
US-9656871-B2 Edge-functionalized graphitic material through mechanochemical process and manufacturing method thereof UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) 2017-05-23 US claimed
CN-105669506-A Synthetic method of 2-thiophenylbenzoic acid 温州大学 2016-06-15 CN claimed
EP-2733116-A1 GRAPHITE HAVING EDGES FUNCTIONALIZED BY A MECHANICAL-CHEMICAL TECHNIQUE, AND METHOD FOR MANUFACTURING SAME UNIST Academy-Industry Research Corporation (KR) 2014-05-21 EP claimed
CN-103355294-A O-(4-fluorine) thiophenyl benzoic acid water dispersible granule and preparation method thereof UNIV NANKAI 2013-10-23 CN claimed
US-20130018204-A1 EDGE-FUNCTIONALIZED GRAPHITIC MATERIAL THROUGH MECHANOCHEMICAL PROCESS AND MANUFACTURING METHOD THEREOF UNIST ACADEMY-INDUSTRY RESEARCH CORPORATION (KR) 2013-01-17 US claimed
CN-101525333-B Synthesis method of metixene hydrochloride UNIV EAST CHINA NORMAL 2011-04-27 CN claimed
CN-101525333-A Synthesis method of metixene hydrochloride UNIV EAST CHINA NORMAL 2009-09-09 CN claimed
WO-2009055631-A1 CALCILYTIC COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2009-04-30 WO claimed
EP-0481522-B1 Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace MERRELL PHARMA INC (US) 1997-12-29 EP claimed
EP-0481522-A1 Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace MERRELL PHARMACEUTICALS INC. (US) 1992-04-22 EP claimed
US-4393072-A Thienylbenzoic acid derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1983-07-12 US claimed
EP-0011282-B1 THIENYLBENZOIC-ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS HOECHST AKTIENGESELLSCHAFT (DE) 1983-02-16 EP claimed
US-12378254-B2 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2025-08-05 US disclosed
EP-4475828-A1 METHODS FOR MONITORING PATIENT RESPONSE TO TREATMENT OF RETINAL OXIDATIVE DISEASES Biojiva LLC (US) 2024-12-18 EP disclosed
CN-118994095-A Small molecule inhibitor and preparation method and application thereof 上海医药工业研究院有限公司 2024-11-22 CN disclosed
US-4137391-A Continuous solution polymerization of a conjugated diene with a monovinylaromatic compound using alkoxysilicon treating agents in the first reactor means of a reactor series PHILLIPS PETROLEUM COMPANY (US) 1979-01-30 US disclosed
US-4117017-A PROCESS FOR PREPARATION OF THIOLS USING A BENZOPINACOL INITIATOR W. R. GRACE & CO. (US) 1978-09-26 US disclosed
US-4070361-A Mercaptoalkylsulfonyl proline and pipecolic acid and esters thereof E. R. SQUIBB & SONS, INC. (US) 1978-01-24 US disclosed
US-3994920-A APPETITE SUPPRESSANT, ANTIDEPRESSANT AMERICAN HOME PRODUCTS CORPORATION (US) 1976-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12378254-B2 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators HCRTR2, HCRTR1, OXTR ALOX15 719/4885LMNA 4524/4885KDM4E 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.